Lumida
/CABA
⌘K
Cabaletta Bio Inc

Cabaletta Bio Inc

CABA
$2.83USD+5.99%+0.16 today

MARKET CAP

461.4M

P/E (TTM)

FWD P/E

DAY RANGE

$3 – $3

52W RANGE

$1
$4

AI Summary

Stalk
TrimMedium

In a Stage 4 decline with confirmed lower highs and lower lows, the medium-term bias remains bearish. Despite the Bearish Exhaustion pattern suggesting seller fatigue, price has only bounced into declining 9/21 EMA resistance without a decisive rejection. With no clear upside displacement, execution is deferred toward a trim on rallies into the 9 and 21 EMA zone and prior resistance region.

  • Kappa-201 achieved favorable risk-benefit in early trials, fueling FDA registrational talks set for early 2025.
  • Immunomodulator-free response rates high across lupus and systemic sclerosis cohorts, filling a large treatment gap.
  • Net income of -$43.5M and operating cash flow of -$42.6M underscore rapid cash burn.
Full analysis →
Insider Trades11 trades
DateSideTickerInsiderRoleSharesPriceMkt Cap52W High52W LowValue% ChgRuleAI View
Jan 21, 2026BuyCABAMichael GerardGeneral Counsel6,600$2.27$461.4M-33.10%+124.60%$15.0KTrim
Jan 21, 2026BuyCABADavid J. ChangChief Medical Officer8,800$2.26$461.4M-33.10%+124.60%$19.9KTrim
Jan 21, 2026BuyCABAGwendolyn BinderPresident, Science & Tech.11,312$2.19$461.4M-33.10%+124.60%$24.8K+56.56%Trim
Jan 21, 2026BuyCABASteve GavelChief Commercial Officer22,170$2.27$461.4M-33.10%+124.60%$50.2KTrim
Jan 21, 2026BuyCABASteven NichtbergerPresident & CEO45,000$2.24$461.4M-33.10%+124.60%$100.8K+4.56%Trim
Jan 19, 2024SellCABAGwendolyn Binder22,000$10.30$461.4M-33.10%+124.60%$226.5K+0.00%10b5-1Trim
Dec 19, 2023SellCABAGwendolyn Binder22,000$11.45$461.4M-33.10%+124.60%$251.9K+0.00%10b5-1Trim
Nov 20, 2023SellCABAGwendolyn Binder22,000$9.41$461.4M-33.10%+124.60%$207.1K+0.00%10b5-1Trim
Oct 19, 2023SellCABAGwendolyn Binder22,000$7.18$461.4M-33.10%+124.60%$158.0K+0.00%10b5-1Trim
Sep 19, 2023SellCABAGwendolyn Binder22,000$9.29$461.4M-33.10%+124.60%$204.3K+0.00%10b5-1Trim
Aug 21, 2023SellCABAGwendolyn Binder22,000$7.21$461.4M-33.10%+124.60%$158.7K+0.00%10b5-1Trim